Neumonía por Stenotrophonomas

Autores/as

  • Verny Huertas Franco Hospital Clínica Bíblica
  • María Isabel Lacayo Pallais Hospital Clínica Bíblica

DOI:

https://doi.org/10.51481/amc.v56i1.828

Palabras clave:

Neumonía, Stenotrophomonas maltophilia, S. maltophilia, paciente inmunocompetente, infección extrahospitalaria

Resumen

La Stenotrophomonas maltophilia es un bacilo gram negativo ambiental emergente que ha venido posicionándose entre el grupo de microorganismos multirresistentes como causa de infección en diversos órganos en ambiente hospitalario y en la comunidad. Se reporta este caso de insuficiencia respiratoria con neumonía severa por S. maltophilia adquirida en la comunidad en una paciente inmunocompetente que tuvo una rápida respuesta a tratamiento con trimetoprim sulfametoxazol cuando se logró identificar la bacteria.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Hugh R, Leifsin E. A description of the type strain of Pseudomonas maltophilia. Int Bull Bacteriol Nomencl Taxon 1963;13:133-138

Sara Stamps, Aimee Zaas. Stenotrophomonas maltophilia. UpToDate, Inc. 2012.

W John Looney. Stenotrophomonas: An emerging opportunist human pathogen. Lancet Infect 2009; 9: 312-323

Victor MA, Arpi M, Brunn B, Jonsson V, Hansen MM. Xanthomonas maltophilia in immune compromised hematological patients. Scand J Infect Dis 1994; 26:163-170.

Jang TN, Wang LS, Liu CY. Xanthomonas maltophilia bacteremia:

an analysis of 32 cases. J Formos Med Assoc 1992; 91:1170-1176.

Lockhart SR. Antimicrobial resistance among gram negative Bacilli causing infections in intensive care unit patients in the United States between 1993-2004. J Clin Microbiol 2007; 45:3352-3359.

Razvi S. Respiratory microbiology of patients with cystic fibrosis in the United States 1995-2005. Chest 2009;136:1554-1560.

Jones RN. Microbiological etiologies of Hospital acquired bacterial pneumonia and ventilator associated bacterial pneumonia. Clin Infect Dis 2010;51:881-887.

Pearlman E, Butala S, Bilello L, Stauffer J. Stenotrophomona maltophilia (SM) in ambulatory patient population. 12th European Congress of Clinical Microbiology and infectious diseases. 2002 April 24-27, Milan, Italy. Abstract P1435.

Brooke Joanna S. Stenotrophomonas maltophilia: An Emerging Global Opportunistic Pathogen. Clinical Microbiol Rev 2012; Vol 25 No.1:2-41.

Gales AC, Jones RN, Forward KR, Liñares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistance Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features and trends in the Sentry Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 2001; 32 Suppl 2:104-13.

Hae-Sung Chung, Seong Hong, Young ReeKim. Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from Korea and the activity of antimicrobial combinations against isolates. J Korean Med Society 2013 Vol 24 No.1:62-68.

Wai Kan KT, Ka Lok RL, LI A. Computed tomography features of Stenotrophomonas maltophilia pneumonia in patients with neutropenic fever: Report of two cases. Multidisc, Respiratory Medicine 2013; 8:14.

Li Xz, Zhang L, Poole K. Smec, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2002; 46:333-43.

Martinez JL. Antibiotics and antibiotic resistance genes in natural environments. Science 2008; 321:365-367.

Wood GC, Underwood EI, Crose MA, Swanson JM, Fabian TC. Treatment of Recurrent Stenotrophomonas maltophilia ventilator associated pneumonia with doxycycline and aerosolized colistin. Ann Pharmacother 2010; 44:1665-1668.

Descargas

Publicado

2014-01-30 — Actualizado el 2014-01-30

Versiones

Cómo citar

Franco, V. H., & Pallais, M. I. L. (2014). Neumonía por Stenotrophonomas. Acta Médica Costarricense, 56(1), 27–30. https://doi.org/10.51481/amc.v56i1.828